Intersect ENT (XENT) Tops Q2 EPS by 5c; Guides FY16

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Intersect ENT (XENT) Tops Q2 EPS by 5c; Guides FY16

Intersect ENT Reports Second Quarter 2016 Results

August 2, 2016 4:07 PM EDT

Revenue Increased 27% Year Over Year; Gross Margin at 84%

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2016.

Second quarter 2016 revenue was $19.3 million, representing a 27% increase over the second quarter 2015. Second quarter 2016 gross margin was 84% compared to 81% in the second quarter 2015.

Key recent product development milestones include:

... More